Mark Chin

Companies

• Disc Medicine, Inc.Board member Jan 3, 2023 to now¹
• Harpoon Therapeutics, Inc.Board member Feb 7, 2019 to Mar 11, 2024²
• Iterum Therapeutics plcBoard member May 24, 2018 to Jun 15, 2023³
• Enliven Therapeutics, Inc.Board member Mar 11, 2020 to Jun 3, 2022⁴
• Pyxis Oncology, Inc.Board member Oct 7, 2021 to Apr 4, 2022⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN2,344,072 shares⁶$89.8M at $38.33Jun 3, 2022
• POPyxis Oncology, Inc. PYXS66,831 shares⁷$117.0K at $1.75Apr 21, 2022
• ITIterum Therapeutics plc18,306 shares⁸Jun 15, 2023
• HTHarpoon Therapeutics, Inc.0 shares⁹Mar 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 11, 2024Returned to company 13,224 shares of Harpoon Therapeutics, Inc.⁹
• Mar 8, 2024Granted 424 shares of Harpoon Therapeutics, Inc.⁹
• Jan 1, 2024Granted 1,072 shares of Harpoon Therapeutics, Inc.¹⁰
• Nov 27, 2023Granted 5,000 shares of Harpoon Therapeutics, Inc.¹¹
• Oct 1, 2023Granted 3,035 shares of Harpoon Therapeutics, Inc.¹²
• Jul 1, 2023Granted 18,656 shares of Harpoon Therapeutics, Inc.¹³
• Jun 15, 2023Exercised options 15,853 shares of Iterum Therapeutics plc⁸
• Apr 1, 2023Granted 18,285 shares of Harpoon Therapeutics, Inc.¹⁴
• Jun 23, 2022Exercised options 36,798 shares of Iterum Therapeutics plc¹⁵
• Apr 21, 2022Sold 1,745,761 shares at $3.05 of Pyxis Oncology, Inc.⁷
• Mar 31, 2022Granted 66,831 shares of Pyxis Oncology, Inc.¹⁶
• Oct 13, 2021Bought 312,500 shares at $16.00 of Pyxis Oncology, Inc.¹⁷
• Oct 13, 2021Converted 1,433,261 shares of Pyxis Oncology, Inc.¹⁷